QUIKSCREEN
Syntron Bioresearch, Inc.
Application Filed: 1995-09-27
Trademark Application Details
REGISTERED AND RENEWED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 74736126 |
| Registration Number | 2573977 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Law Office Assigned | M70 |
| Employee Name | SHANAHAN, WILLIAM PATR |
Timeline
| 1995-09-27 | Application Filed |
| 1997-11-01 | Date of First Use |
| 2000-08-08 | Published for Opposition |
| 2002-05-28 | Trademark Registered |
| 2012-04-19 | Location: GENERIC WEB UPDATE |
| 2012-04-19 | Status: Live/Registered |
| 2012-05-28 | Renewal Date |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Syntron Bioresearch, Inc. |
| Address | 2774 Loker Avenue West Carlsbad CA 92008 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | medical diagnostic reagents bound to immunochromatographic membranes for use in detecting the presence of drugs or drug metabolites in urine |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 1996-03-21 | 1 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 1996-03-28 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1996-04-11 | 3 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1996-10-15 | 4 CRFA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 1997-03-14 | 5 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION MAILED | 1997-03-24 | 6 CNSL F:First Action |
| ASSIGNED TO EXAMINER | 1997-10-16 | 7 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 1997-11-25 | 8 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1998-05-19 | 9 CRFA I:Incoming Correspondence |
| FINAL REFUSAL MAILED | 1998-07-17 | 10 CNFR O:Outgoing Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 1999-01-19 | 11 CRFA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 1999-02-17 | 12 DOCK D:Assigned to Examiner |
| EX PARTE APPEAL-INSTITUTED | 1999-03-10 | 13 EXPI T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 1999-03-12 | 14 JURT T:TTAB Proceeding |
| CONTINUATION OF FINAL REFUSAL MAILED | 1999-04-26 | 15 CNCF O:Outgoing Correspondence |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 1999-08-31 | 16 JURT T:TTAB Proceeding |
| EXAMINERS STATEMENT MAILED | 1999-10-29 | 17 CNES O:Outgoing Correspondence |
| EX PARTE APPEAL-REFUSAL REVERSED | 2000-05-15 | 18 EXPR T:TTAB Proceeding |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2000-05-24 | 19 CNSA P: |
| NOTICE OF PUBLICATION | 2000-07-07 | 20 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2000-08-08 | 21 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2000-10-31 | 22 NOAM O:Outgoing Correspondence |
| EXPARTE APPEAL TERMINATED | 2001-08-28 | 23 EXPT T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2001-08-28 | 24 JURT T:TTAB Proceeding |
| ASSIGNED TO EXAMINER | 2001-08-28 | 25 DOCK D:Assigned to Examiner |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2001-03-14 | 26 CRFA I:Incoming Correspondence |
| USE AMENDMENT FILED | 2001-03-14 | 27 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2002-01-31 | 28 SUPC I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2002-01-31 | 29 DOCK D:Assigned to Examiner |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2002-02-08 | 30 CRFA I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2002-02-26 | 31 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2002-05-28 | 32 R.PR A:Allowance for Publication |
| CASE FILE IN TICRS | 2007-09-05 | 33 CFIT O:Outgoing Correspondence |
| TEAS SECTION 8 & 15 RECEIVED | 2008-04-14 | 34 E815 I:Incoming Correspondence |
| ASSIGNED TO PARALEGAL | 2008-04-29 | 35 PLGL A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2008-05-02 | 36 C15A O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2012-03-27 | 37 TCCA I:Incoming Correspondence |
| TEAS SECTION 8 & 9 RECEIVED | 2012-03-27 | 38 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2012-04-19 | 39 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2012-04-19 | 40 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2012-04-19 | 41 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2012-04-19 | 42 NA89 E:E-Mail |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2021-05-28 | 43 REM2 E:E-Mail |
| CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | 2022-12-09 | 44 CAEX O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 QUIKSCREEN 74736126 2573977 Live/Registered |
Syntron Bioresearch, Inc. 1995-09-27 |
 QUIKSCREEN 74628752 2076096 Live/Registered |
IMMUCOR GTI DIAGNOSTICS, INC. 1995-02-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 